To further understand the association between LRP1B dysregulation and tumor immune microenvironment alteration, we performed a combined bulk RNA-seq and single-cell RNA-seq analysis based on 15 racially diverse, treatment-naïve CRC patient tissue samples (22). Here, LRP1B is linked to colorectal carcinoma.